top of page
< Back

Travoprost


Mechanism of action:

Travoprost is a prostaglandin F2α analog. It is a prodrug that, after corneal absorption, is hydrolyzed within the eye into its active form, travoprost acid. Travoprost acid selectively binds to prostaglandin F receptors in the iris and ciliary body, triggering extracellular matrix remodeling, such as collagen reorganization, which lowers resistance in the uveoscleral outflow pathway and thereby increases aqueous humor drainage.

Reference(s):

1. Waugh J et al. (2002). Travoprost. Drugs Aging. 


2. Whitson JT et al. (2002). Travoprost--a new prostaglandin analogue for the treatment of glaucoma. Expert Opin Pharmacother. 


3. Al-Jazzaf AM et al. (2003). Travoprost: a potent ocular hypotensive agent. Drugs Today (Barc).

bottom of page